Yuehui Wu

1.6k total citations
34 papers, 822 citations indexed

About

Yuehui Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuehui Wu has authored 34 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Yuehui Wu's work include Statistical Methods in Clinical Trials (5 papers), Protein Degradation and Inhibitors (5 papers) and Optimal Experimental Design Methods (5 papers). Yuehui Wu is often cited by papers focused on Statistical Methods in Clinical Trials (5 papers), Protein Degradation and Inhibitors (5 papers) and Optimal Experimental Design Methods (5 papers). Yuehui Wu collaborates with scholars based in United States, China and Canada. Yuehui Wu's co-authors include Valerii V. Fedorov, Vladimir Dragalin, Andrew A. Renshaw, Jerome P. Richie, Shouzhuo Yao, Guozhu Liu, Yang Shan, Ming‐Hui Chen, Bo Chen and Dongxiu He and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Yuehui Wu

33 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuehui Wu United States 16 265 196 157 141 113 34 822
Nibedita Bandyopadhyay United States 11 176 0.7× 316 1.6× 247 1.6× 67 0.5× 12 0.1× 19 1.3k
Andrew G. Stead United States 21 414 1.6× 501 2.6× 954 6.1× 40 0.3× 13 0.1× 54 2.0k
Binbin Tan China 14 618 2.3× 46 0.2× 121 0.8× 38 0.3× 17 0.2× 25 942
Min Song China 21 645 2.4× 67 0.3× 213 1.4× 13 0.1× 32 0.3× 61 1.2k
Wan‐Lun Wang Taiwan 20 205 0.8× 37 0.2× 106 0.7× 14 0.1× 43 0.4× 72 890
Kelloff Gj United States 10 207 0.8× 109 0.6× 166 1.1× 5 0.0× 44 0.4× 17 744
Suzy Van Sanden Belgium 15 414 1.6× 262 1.3× 156 1.0× 5 0.0× 7 0.1× 76 1.1k
Konstantinos Theofilatos United Kingdom 17 401 1.5× 66 0.3× 39 0.2× 26 0.2× 126 1.1× 58 976
Sha Cao United States 18 664 2.5× 131 0.7× 193 1.2× 5 0.0× 18 0.2× 71 1.2k
Syril Pettit United States 22 820 3.1× 36 0.2× 72 0.5× 29 0.2× 3 0.0× 47 1.7k

Countries citing papers authored by Yuehui Wu

Since Specialization
Citations

This map shows the geographic impact of Yuehui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuehui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuehui Wu more than expected).

Fields of papers citing papers by Yuehui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuehui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuehui Wu. The network helps show where Yuehui Wu may publish in the future.

Co-authorship network of co-authors of Yuehui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuehui Wu. A scholar is included among the top collaborators of Yuehui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuehui Wu. Yuehui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mingming, et al.. (2024). Vagus nerve stimulation modulating the directed brain network of patients with drug-resistant epilepsy. Biomedical Signal Processing and Control. 95. 106361–106361. 4 indexed citations
2.
Guo, Yongkun, et al.. (2023). Alterations in brain network functional connectivity and topological properties in DRE patients. Frontiers in Neurology. 14. 1238421–1238421.
3.
Wang, Xinjun, et al.. (2023). Brain functional connectivity and network characteristics changes after vagus nerve stimulation in patients with refractory epilepsy. Translational Neuroscience. 14(1). 20220308–20220308. 5 indexed citations
4.
Paganoni, Sabrina, et al.. (2023). Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls. Annals of Clinical and Translational Neurology. 10(12). 2297–2304. 12 indexed citations
5.
Huang, Zhigang, et al.. (2022). Urban heat vulnerability: A dynamic assessment using multi-source data in coastal metropolis of Southeast China. Frontiers in Public Health. 10. 989963–989963. 19 indexed citations
6.
Wu, Yuehui, et al.. (2022). Chronobiological Patterns of Aneurysmal Subarachnoid Hemorrhage in Central China. Global Heart. 17(1). 29–29. 3 indexed citations
7.
Yang, Shuwen, et al.. (2021). The Role of Aspirin in the Management of Intracranial Aneurysms: A Systematic Review and Meta-Analyses. Frontiers in Neurology. 12. 646613–646613. 7 indexed citations
8.
Wu, Yuehui, Jin Zheng, Yun Sun, et al.. (2021). Non-Coding RNAs as Circulating Biomarkers for the Diagnosis of Intracranial Aneurysm: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 30(6). 105762–105762. 2 indexed citations
9.
Cousin, Sophie, Jean‐Yves Blay, Irene García, et al.. (2020). BET inhibitor molibresib for the treatment of advanced solid tumors: Final results from an open-label phase I/II study.. Journal of Clinical Oncology. 38(15_suppl). 3618–3618. 5 indexed citations
10.
Bauer, Todd M., Benjamin Besse, Alex Martínez‐Martí, et al.. (2019). Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC. Journal of Thoracic Oncology. 14(10). 1828–1838. 61 indexed citations
11.
O’Dwyer, Peter J., Sarina A. Piha‐Paul, Christopher A. French, et al.. (2016). Abstract CT014: GSK525762, a selective bromodomain (BRD) and extra terminal protein (BET) inhibitor: results from part 1 of a phase I/II open-label single-agent study in patients with NUT midline carcinoma (NMC) and other cancers. Cancer Research. 76(14_Supplement). CT014–CT014. 26 indexed citations
12.
Wu, Yuehui, et al.. (2015). ATPase inhibitory factor 1 is a potential prognostic marker for the migration and invasion of glioma. Oncology Letters. 10(4). 2075–2080. 28 indexed citations
13.
Wu, Yuehui, et al.. (2014). Evaluation of TAZ expression and its effect on tumor invasion and metastasis in human glioma. Asian Pacific Journal of Tropical Medicine. 7(10). 757–760. 10 indexed citations
14.
15.
Gandara, David R., Sandrine Hiret, George R. Blumenschein, et al.. (2013). Oral MEK1/MEK2 inhibitor trametinib (GSK1120212) in combination with docetaxel in KRAS-mutant and wild-type (WT) advanced non-small cell lung cancer (NSCLC): A phase I/Ib trial.. Journal of Clinical Oncology. 31(15_suppl). 8028–8028. 23 indexed citations
16.
He, Dongxiu, Yang Shan, Yuehui Wu, et al.. (2011). Simultaneous determination of flavanones, hydroxycinnamic acids and alkaloids in citrus fruits by HPLC-DAD–ESI/MS. Food Chemistry. 127(2). 880–885. 86 indexed citations
17.
Fedorov, Valerii V., Yuehui Wu, & Rongmei Zhang. (2011). Optimal dose‐finding designs with correlated continuous and discrete responses. Statistics in Medicine. 31(3). 217–234. 30 indexed citations
18.
Dragalin, Vladimir, Valerii V. Fedorov, & Yuehui Wu. (2008). Two‐stage design for dose‐finding that accounts for both efficacy and safety. Statistics in Medicine. 27(25). 5156–5176. 33 indexed citations
19.
20.
Calleman, Carl Johan, Yuehui Wu, Gaochao Tian, et al.. (1994). Relationships between Biomarkers of Exposure and Neurological Effects in a Group of Workers Exposed to Acrylamide. Toxicology and Applied Pharmacology. 126(2). 361–371. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nibedita Bandyopadhyay Breakdown of academic impact, for papers by Andrew G. Stead Breakdown of academic impact, for papers by Binbin Tan Breakdown of academic impact, for papers by Min Song Breakdown of academic impact, for papers by Wan‐Lun Wang Breakdown of academic impact, for papers by Kelloff Gj Breakdown of academic impact, for papers by Suzy Van Sanden Breakdown of academic impact, for papers by Konstantinos Theofilatos Breakdown of academic impact, for papers by Sha Cao Breakdown of academic impact, for papers by Syril Pettit
Rankless by CCL
2026